University of Michigan "Nephrology Research BioBank"
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT00381121
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.
Key Dates
- Start date
- Sep 30, 2006
- Status verified
- Apr 2025
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 420 participants (estimated)
Arms
- Arm: Kidney disease cohortIndividuals with a clinically indicated biopsy are recruited and/or surplus tissue that remains from past clinical interventions is obtained.
Central Contacts
- Chrysta Lienczewsky734-764-2924
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | Matthias Kretzler, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By condition
By specialty
By research site
Related Studies
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterRecruiting · University of Michigan · Ann Arbor, Michigan
- Expanding and Promoting Alternative Care and kNowledge in Decision-making TrialEnrolling By Invitation · George Washington University · San Francisco, California
- A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseasePHASE2 · Recruiting · Novo Nordisk A/S · San Dimas, California
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortPHASE1 · Recruiting · AstraZeneca · Glendale, California